Concept Clearance » Biomarker Development and Validation: Establishing Standards of Evidence for their Context of Use in Clinical Trials

This initiative is intended to encourage the necessary later stages of development and validation of biomarkers with putative value for use in clinical trials, including multi-sites testing and validation for regulatory ‘context of use’ (e.g., diagnostic, enrichment, stratification).

via NIMH | Recent Updates

Leave a Reply